The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation

被引:7
|
作者
Pessach, Ilias [1 ]
Tsirigotis, Panagiotis [1 ]
Nagler, Arnon [2 ]
机构
[1] Natl & Kapodistrian Univ Athens, ATTIKO Univ Hosp, Div Hematol, Dept Internal Med 2, Athens, Greece
[2] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel
关键词
GI-tract; allo-HSCT; GVHD; paneth cells; Mast Cells (MCs); Innate Lymphoid Cells (ILCs); Antigen Presenting Cells (APCs); Toll-like receptors (TLRs); NOD-like receptors (NLRs); intestinal microbiota; VERSUS-HOST-DISEASE; INNATE LYMPHOID-CELLS; ESCHERICHIA-COLI STRAINS; NECROSIS-FACTOR-ALPHA; CHAIN FATTY-ACIDS; IMMUNE-RESPONSES; DENDRITIC CELLS; INTESTINAL MICROBIOTA; SECONDARY DISEASE; GUT MICROBIOTA;
D O I
10.1080/17474086.2017.1288566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The GI-tract is a major target for both the intensive chemo and/or radiotherapy conditioning as well as for GVHD and therefore is closely associated with transplant outcome. Apart from being a target, the GI-tract is also a mediator and therefore is also a key player of the pathogenetic process following allogeneic transplantation.Areas covered: The intestinal homeostasis is regulated through complicated interactions between the key players of this process which are the intestinal epithelium, the intestinal immune system, and the intestinal microbiota. A brief description of these elements, based on published english-language articles in PubMed, as well as their role during the process of allo-HSCT is discussed in this review.Expert commentary: Data on GI-tract properties suggest a central role for the intestine in regulation of immunity, both in healthy - steady state conditions and in pathological states such as during allo-HSCT. Given the fact that in the allogeneic transplant setting severe complications such as infections and GVHD are limiting this treatment modality, understanding the mechanisms that mediate intestinal homeostasis could lead to new preventive methods and improved outcomes.
引用
收藏
页码:315 / 326
页数:12
相关论文
共 50 条
  • [41] Sequelae of pediatric allogeneic hematopoietic stem cell transplantation
    Diamond, C.
    Oeffinger, K.
    Hall, R.
    Driscoll, T.
    Cardones, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B10 - B10
  • [42] Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendoza, Maria Alejandra
    Imlay, Hannah
    VIRUSES-BASEL, 2025, 17 (03):
  • [43] Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Blaser, Bradley W.
    Kim, Haesook
    Plutzky, Jorge
    Alyea, Edwin, III
    Ho, Vincent
    Cutler, Corey
    Armand, Philippe
    Koreth, John
    Antin, Joseph H.
    Soiffer, Robert
    BLOOD, 2010, 116 (21) : 1419 - 1419
  • [44] Transfusion policy in allogeneic hematopoietic stem cell transplantation
    Topcuoglu, Pervin
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 174 - 177
  • [45] Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
    Buxbaum, Nataliya Prokopenko
    Pavletic, Steven Z.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
    Atalla, Angelo
    Hallack Neto, Abrahao Elias
    Siqueira, Denise Bittencourt
    Toledo, Gabriela Cumani
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88 (06) : 216 - 219
  • [47] Erythrocytosis after allogeneic hematopoietic stem cell transplantation
    Hino, Yutaro
    Doki, Noriko
    Kurosawa, Shuhei
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Hattori, Kenichiro
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [48] Jaundice After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendizabal, Manuel
    Chen, Terina
    Reddy, K. Rajender
    HEPATOLOGY, 2009, 50 (06) : 2044 - 2045
  • [49] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Q. Jiang
    B. H. Zhang
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 504 - 506
  • [50] Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
    Zhang, Lining
    Yang, Fan
    Feng, Sizhou
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11